08.17.12
AIDP, Inc., City of Industry, CA, the distributors of Magtein magnesium L-threonate, has been awarded two patents for magnesium compositions and uses for cognitive function (Patent 8,178,118) and neurological disorders (Patent No. 8,142,803).
The patents, titled “Magnesium compositions and uses thereof for cognitive function” (Patent No. 8,178,118) and “Magnesium compositions and uses thereof for neurological disorders” (Patent No. 8,142,803) are among the four U.S. patents awarded from seven ongoing patent applications, including international rights. These patents protect Magtein’s unique magnesium compositions and its use for any magnesium L-threonate-containing food, nutritional supplements and drugs for enhancing cognitive function or ameliorating the effects of a neurological disorder. The use of these products is applicable for improving the health of people suffering from loss of cognitive function, loss of memory, Alzheimer’s disease, depression, attention deficit hyperactivity disorder, Amyotrophic lateral sclerosis (ALS), Parkinson’s disease, migraine, anxiety disorder, and mood disorder, as some representative of cognitive and neurological disorders.
